外国制药企业在中国开展临床试验现况分析---基于Clinical Trials.gov网站登记数据的统计分析 : = Analysis of clinical trials supported by foreign pharmaceutical industries in China
Objective:To summarize and analyze the status of clinical trials in China using the data from "ClinicalTrials.gov" database.Methods: "ClinicalTrials.gov" provides regularly up-to-date information on federally and privately supported clinical research in human volunteers.It is the biggest clinical trial registry database all over the world.The worldwide information on clinical trials(including all data about China) was collected from "ClinicalTrials.gov".Results: The number of clinical trials,which were supported by industry by now,was 97 in China.Among the trials,there were 58 multinational clinical trials,and 39 clinical trials conducted only in China.The most popular diseases were cancer,circulation system disorders,central nervous system disorders and infection diseases.All of the drugs used for clinical trials conducted only in China were already marketed in a foreign country,so all the clinical trials were conducted either for seeking new indications or for import.On the other hand,drugs used for multinational clinical trials were those developed in phase 3 or in phase 4 in a foreign country;the aims were to gain Chinese data or to promote marketing.Half of the trials conducted only in China and 67% trials conducted multinationally were double blind,randomized trials.Most of the clinical trials in China,either the ones conducted only in China or multinational ones,were conducted in about 10 units.Conclusion: The foreign pharmaceutical industries let Chinese take part in a lot of clinical trials in order to develop a new medicine rapidly..
外国制药企业在中国开展临床试验现况分析——基于Clinical Trials.gov网站登记数据的统计分析.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2008-11-15 2008 |
|---|---|
| Erschienen: |
2008-11-15 |
| Enthalten in: |
Zur Gesamtaufnahme - year:2008 |
|---|---|
| Enthalten in: |
Zhong guo xin yao za zhi - (2008), 21 vom: 15. Nov., Seite 91-94 Original Letters: Enthalten in 中国新药杂志 (DE-600)2995671-7 (DE-600)2995671-7 北京市 |
| Reihe: |
China Academic Journals (CAJ), E, 医药卫生科技 = Medicine & Public Health China Academic Journals (CAJ), J, 经济与管理科学 = Economics & Management |
|---|
| Sprache: |
Chinesisch |
|---|
| Weiterer Titel: |
Analysis of clinical trials supported by foreign pharmaceutical industries in China |
|---|
| Beteiligte Personen: |
姚晨 [VerfasserIn] |
|---|
| Links: |
oversea.cnki.net [lizenzpflichtig] |
|---|
| Themen: |
三菱田辺製薬株式会社 |
|---|
| Umfang: |
4 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
CAJ045744629 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | CAJ045744629 | ||
| 003 | DE-627 | ||
| 005 | 20221030175715.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 220928s2008 cc |||||o 00| ||chi c | ||
| 035 | |a (DE-627)CAJ045744629 | ||
| 035 | |a (SBB-XA)CAJ_ZXYZ200821022 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a chi | ||
| 044 | |c XB-CN | ||
| 084 | |a ASIEN |q DE-1a |2 fid | ||
| 084 | |a F426.72 |2 clc | ||
| 100 | 0 | |a 姚晨 |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a 外国制药企业在中国开展临床试验现况分析---基于Clinical Trials.gov网站登记数据的统计分析 |b = Analysis of clinical trials supported by foreign pharmaceutical industries in China |
| 246 | 3 | 1 | |a Analysis of clinical trials supported by foreign pharmaceutical industries in China |
| 264 | 1 | |c 2008-11-15 | |
| 300 | |a 4 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 490 | 0 | |a China Academic Journals (CAJ) |a E |a 医药卫生科技 = Medicine & Public Health | |
| 490 | 0 | |a China Academic Journals (CAJ) |a B |a 理工B(化学化工冶金环境矿业) = Chemistry/ Metallurgy/ Environment/ Mine Industry | |
| 490 | 0 | |a China Academic Journals (CAJ) |a J |a 经济与管理科学 = Economics & Management | |
| 520 | |a Objective:To summarize and analyze the status of clinical trials in China using the data from "ClinicalTrials.gov" database.Methods: "ClinicalTrials.gov" provides regularly up-to-date information on federally and privately supported clinical research in human volunteers.It is the biggest clinical trial registry database all over the world.The worldwide information on clinical trials(including all data about China) was collected from "ClinicalTrials.gov".Results: The number of clinical trials,which were supported by industry by now,was 97 in China.Among the trials,there were 58 multinational clinical trials,and 39 clinical trials conducted only in China.The most popular diseases were cancer,circulation system disorders,central nervous system disorders and infection diseases.All of the drugs used for clinical trials conducted only in China were already marketed in a foreign country,so all the clinical trials were conducted either for seeking new indications or for import.On the other hand,drugs used for multinational clinical trials were those developed in phase 3 or in phase 4 in a foreign country;the aims were to gain Chinese data or to promote marketing.Half of the trials conducted only in China and 67% trials conducted multinationally were double blind,randomized trials.Most of the clinical trials in China,either the ones conducted only in China or multinational ones,were conducted in about 10 units.Conclusion: The foreign pharmaceutical industries let Chinese take part in a lot of clinical trials in order to develop a new medicine rapidly. | ||
| 520 | |a 外国制药企业在中国开展临床试验现况分析——基于Clinical Trials.gov网站登记数据的统计分析 | ||
| 610 | 2 | 4 | |a 北京大学第一医院 |
| 610 | 2 | 4 | |a 三菱田辺製薬株式会社 |
| 610 | 2 | 4 | |a 东京大学医学系研究科 |
| 650 | 4 | |a 医药卫生科技 | |
| 650 | 4 | |a Medicine & Public Health | |
| 650 | 4 | |a 理工B(化学化工冶金环境矿业) | |
| 650 | 4 | |a Chemistry/ Metallurgy/ Environment/ Mine Industry | |
| 650 | 4 | |a 经济与管理科学 | |
| 650 | 4 | |a Economics & Management | |
| 650 | 4 | |a 工业部门经济 | |
| 650 | 4 | |a 中国工业经济 | |
| 650 | 4 | |a 工业经济 | |
| 650 | 4 | |a 经济 | |
| 650 | 4 | |a 国际多中心临床试验 | |
| 650 | 4 | |a 新药研发 | |
| 650 | 4 | |a 外国制药企业 | |
| 700 | 0 | |a 杉野敬一 |4 oth | |
| 700 | 0 | |a 大桥靖雄 |4 oth | |
| 700 | 0 | |a 龚倩 |4 oth | |
| 773 | 0 | 8 | |6 880-01 |i Enthalten in |t Zhong guo xin yao za zhi |d Bei jing shi, 1992 |g (2008), 21 vom: 15. Nov., Seite 91-94 |h Online-Ressource |w (DE-627)CAJ000062634 |w (DE-600)2995671-7 |7 nnns |
| 773 | 1 | 8 | |g year:2008 |g number:21 |g day:15 |g month:11 |g pages:91-94 |g extent:4 |
| 856 | 4 | 0 | |u https://oversea.cnki.net/kcms/detail/detail.aspx?dbcode=CJFD&filename=ZXYZ200821022 |x Verlag |z lizenzpflichtig |
| 856 | 4 | 0 | |u http://erf.sbb.spk-berlin.de/han/caj/oversea.cnki.net/kcms/detail/detail.aspx?dbcode=CJFD&filename=ZXYZ200821022 |x Verlag |y CrossAsia Link |z Deutschlandweit zugänglich |
| 880 | 0 | 8 | |6 773-01/Hans |i Enthalten in |t 中国新药杂志 |d 北京市 |h Online-Ressource |w (DE-627)CAJ000062634 |w (DE-600)2995671-7 |7 nnns |
| 912 | |a ZDB-1-CAJ | ||
| 912 | |a GBV_NL_CAJ | ||
| 912 | |a FID-ASIEN | ||
| 912 | |a SSG-OLC-OA3.1A | ||
| 912 | |a SSG-OLC-CAJ | ||
| 936 | u | w | |j 2008 |e 21 |b 15 |c 11 |h 91-94 |g 4 |
| 951 | |a AR | ||
| 952 | |j 2008 |e 21 |b 15 |c 11 |h 91-94 |g 4 | ||
| 980 | |2 11 |1 01 |x 0001 |b 045704015 |c 00 |f 5:FIDXASIA |d --%%-- |e --%%-- |j --%%-- |y k |z 28-09-22 | ||
| 981 | |2 11 |1 01 |x 0001 |y CrossAsia Link |r http://erf.sbb.spk-berlin.de/han/caj/oversea.cnki.net/kcms/detail/detail.aspx?dbcode=CJFD&filename=ZXYZ200821022 | ||